"Designing Growth Strategies is in our DNA"
To get information on various segments, share your queries with us
|
ATTRIBUTE |
DETAILS |
|
Study Period |
2021-2034 |
|
Base Year |
2025 |
|
Estimated Year |
2026 |
|
Forecast Period |
2026-2034 |
|
Historical Period |
2021-2034 |
|
Growth Rate |
CAGR of 12.11% from 2026-2034 |
|
Unit |
Value (USD Billion) |
|
Segmentation |
By Reagents, Origin, Technology, Application, End User and Region |
|
By Reagents |
· Sample & Nucleic Acid Preparation Reagents · Library Preparation Reagents · Library QC & Quantification Reagents · Target Enrichment Reagents · Sequencing Run Reagents & Consumables · Others |
|
By Origin |
· Synthetic · Biological · Mixed |
|
By Technology |
· Next-Generation Sequencing (NGS) · Sanger Sequencing · Third Generation Sequencing · Others |
|
By Application |
· Drug Discovery & Development · Genetic & Rare Disease Research · Biomarker Discovery & Validation · Others |
|
By End User |
· Pharmaceutical & Biotechnology Companies · Academic & Research Institutes · Others · |
|
By Region |
· North America (By Reagents, Origin, Technology, Application, End User, and Country) o U.S. o Canada · Europe (By Reagents, Origin, Technology, Application, End User, and Country/Sub-region) o Germany o U.K. o France o Spain o Italy o Scandinavia o Rest of Europe · Asia Pacific (By Reagents, Origin, Technology, Application, End User, and Country/Sub-region) o China o Japan o India o Australia o Southeast Asia o Rest of Asia Pacific · Latin America (By Reagents, Origin, Technology, Application, End User, and Country/Sub-region) o Brazil o Mexico o Rest of Latin America · Middle East & Africa (By Reagents, Origin, Technology, Application, End User, and Country/Sub-region) o GCC o South Africa o Rest of Middle East & Africa |
Related Reports
Get In Touch With Us
US +1 833 909 2966 ( Toll Free )